Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008 Apr;115(5):653-62.
doi: 10.1111/j.1471-0528.2007.01657.x.

Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids

H Zowall  1 , J A Cairns, C Brewer, D L Lamping, W M W Gedroyc, L Regan
Affiliations
Comparative Study

Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids

H Zowall et al. BJOG. 2008 Apr.

Abstract

Objective: To estimate the cost-effectiveness of a treatment strategy for symptomatic uterine fibroids, which starts with Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) as compared with current practice comprising uterine artery embolisation, myomectomy and hysterectomy.

Design: Cost-utility analysis based on a Markov model.

Setting: National Health Service (NHS) Trusts in England and Wales.

Population: Women for whom surgical treatment for uterine fibroids is being considered.

Methods: The parameters of the Markov model of the treatment of uterine fibroids are drawn from a series of clinical studies of MRgFUS, and from the clinical effectiveness literature. Health-related quality of life is measured using the 6D. Costs are estimated from the perspective of the NHS. The impact of uncertainty is examined using deterministic and probabilistic sensitivity analysis.

Main outcome measures: Incremental cost-effectiveness measured by cost per quality-adjusted life-year (QALY) gained.

Results: The base-case results imply a cost saving and a small QALY gain per woman as a result of an MRgFUS treatment strategy. The cost per QALY gained is sensitive to cost of MRgFUS relative to other treatments, the age of the woman and the nonperfused volume relative to the total fibroids volume.

Conclusions: A treatment strategy for symptomatic uterine fibroids starting with MRgFUS is likely to be cost-effective.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structure of the model.
Figure 2
Figure 2
Two-way sensitivity analysis—cost of MRgFUS versus cost of alternative treatment.
Figure 3
Figure 3
Cost-effectiveness acceptability curve.
See this image and copyright information in PMC

Comment in

References

    1. Manyonda I, Sinthamoney E, Belli A-M. Controversies and challenges in the fibroid management of uterine fibroids. BJOG. 2004;111:95–102. - PubMed
    1. Stewart EA. Uterine fibroids. Lancet. 2001;357:293–8. - PubMed
    1. Banu NS, Manyonda I. Alternative medical and surgical options to hysterectomy. Best Pract Res Clin Obstet Gynaecol. 2005;19:431–49. - PubMed
    1. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100–7. - PubMed
    1. Stewart E, Rabinovici J, Tempany C, Inbar Y, Regan L, Gastout B, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006;85:22–9. - PubMed

Publication types